Clinical Trials
50 trialsEQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Case Comprehensive Cancer Center
INDIGO
Boston Scientific Corporation
ELEGANCE
Nantes University Hospital
Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Cystic Neoplasms and Pancreatic Neuroendocrine Tumors
Institute for Clinical and Experimental Medicine
Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumors
University Health Network, Toronto
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Cedars-Sinai Medical Center
BCB RIV
Institut du Cancer de Montpellier - Val d'Aurelle
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
Mayo Clinic
Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors
University Health Network, Toronto
MGMT-NET
Hospices Civils de Lyon
A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072
Ariceum Therapeutics GmbH
Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors
Barbara Ann Karmanos Cancer Institute
Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies
Xijing Hospital
TNE-IDC-COLE
Hospital Universitari de Bellvitge
Trinav
Abramson Cancer Center at Penn Medicine
TARGETMONITO
UNICANCER
Exploratory Study on the Efficacy of Betaine Hydrochloride in Treating Autoimmune Gastritis
Second Affiliated Hospital, School of Medicine, Zhejiang University
Dual-Tracer Theranostic PET
University of Utah
Liquid-NET
Universiteit Antwerpen
VISIONARY
Peking University
DNET
Asian Institute of Gastroenterology, India
Oral Protein Supplements for Nutritional and Quality of Life Improvement After Pancreatic Resection in Elderly Patients
Yonsei University
DIB-NET
University Hospitals Coventry and Warwickshire NHS Trust
WIN
University Medical Center Groningen
WIN
University Medical Center Groningen
DIVIT-pilot
University Medical Center Groningen
DIVIT Study Diet and Vitamin Supplementation in Patients With a Neuroendocrine Tumor
University Medical Center Groningen
NETest_Sx
Wren Laboratories LLC
Early Identification of Cardiac Involvement in Patients With Carcinoid: Clinical and Prognostic Implications
European Institute of Oncology
RAPNEN
Catholic University of the Sacred Heart
68Ga-DOTATATE PET for Management of Neuroendocrine Tumors
University Health Network, Toronto
Cryoablation of Bone Metastases From Endocrine Tumors
Instituto do Cancer do Estado de São Paulo
Radio-Marker
Erasmus Medical Center
Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers
Stanford University
A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET 2.0)
University Hospital, Antwerp
Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors
Memorial Sloan Kettering Cancer Center
Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency
Vanderbilt-Ingram Cancer Center
FENET-2016
University Hospital of Ferrara
A Biological Study of Resveratrol's Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors
University of Wisconsin, Madison
Efficacy of 177-Lu-DOTA 0, Tyr 3 Octreotate
Instituto Nacional de Cancerologia, Columbia
Applying PET/MR in Neuroendocrine Tumors - Imaging Dynamic Processes in Both Modalities
Tel-Aviv Sourasky Medical Center
Developing a Method Using PET-MR to Improve Staging and Monitoring of Neuroendocrine Tumor
Tel-Aviv Sourasky Medical Center
Endoscopic Ultrasound Guided Radiofrequency Ablation (EUS-RFA) for Small Benign Pancreatic Tumors
National Taiwan University Hospital
Clinic, Pathologic and Genetic Characterization of Patients With Familial Carcinoid Tumors (Study From the GTE, Groupe d'étude Des Tumeurs Endocrines)
CHU de Reims
Proton Boost for Locally Advanced HEAD AND NECK TUMORS
CNAO National Center of Oncological Hadrontherapy
EUS
Asan Medical Center
Combination Targeted Radiotherapy in Neuroendocrine Tumors
University of Iowa
Imaging of Neuroendocrine Tumors With PET and Fluoro-18-DOPA (F-DOPA)
Northwell Health
EUS-FNA
Istituto Clinico Humanitas
SPECT/CT in Endocrine and Neuroendocrine Tumors
Rambam Health Care Campus